Jeffrey S. Aronin
Jeffrey S. Aronin is a bioscience entrepreneur known for innovating, developing and commercializing a record number of novel neurology medicines that improve the lives of seriously ill patients who have few or no treatment options.
In 2017, Jeff founded Paragon Biosciences, where he is chairman and chief executive officer. Paragon is a global life science leader that creates, builds and funds innovative biology-based companies. It accelerates scientific breakthroughs to solve some of society’s most challenging medical problems.
Paragon’s portfolio of high-growth companies includes Harmony Biosciences (NASDAQ: HRMY), Emalex Biosciences and CiRC Biosciences.
Jeff serves on corporate and civic boards including Discover Financial Services, The Aspen Institute and the International Board of the Weizmann Institute of Science.